News and Articles on Ayurveda, Yoga, Kundalini and other Indian way of health and medicines.
In a landmark initiative to ensure safety from COVID-19, Ministry of Health and Family Welfare has taken a decision to allow foreign nationals residing in India to get registered on CoWin portal to take COVID-19 vaccine. They can use their passport as identity document for the purpose of registration on CoWIN portal. Once they are registered on this portal, they will get a slot for vaccination.
Union Ayush Minister Shri Sarbananda Sonowal and MoS for Ayush, Dr. Munjapara Mahendrabhai visited All India Institute of Ayurveda on Sunday and inaugurated Multi-Purpose Yoga Hall & Mini Auditorium. Both the Ministers highly appreciated the work done by AIIA and assured their full-fledged support for further development of the Institute to make it world’s best Ayurveda Institute. Lauding the futuristic plan of the Institute, Shri Sarbananda Sonowal assured all help for establishing the first Bio-Bank of the world in Ayurveda at AIIA.
India crossed the 500 million doses mark in total vaccine shots administered so far on Friday, health minister Mansukh Mandaviya said in a tweet. “India soars high on #COVID19 vaccination, historic record of 50 crore doses administered to date,” the minister said.
‘Ashwagandha’ (Withania somnifera), commonly known as ‘Indian winter cherry’, is a traditional Indian herb that boosts energy, reduces stress and makes the immune system stronger. It is an easily accessible, over-the-counter nutritional supplement in the U.K. and has a proven safety profile. The positive effects of ‘Ashwagandha’ have been observed in Long COVID, which is a multi-system disease with no evidence of its effective treatment or management.
“The facility will be useful for the research and treatment of post-covid heart failure. The increase in the observed prevalence of long-COVID symptoms and post-COVID heart failure calls for long-COVID clinics to collect patient data and biospecimens that can be biobank for future research. Through the NHFB, researchers can get access to well-annotated biological specimens linked to clinical data while maintaining appropriate standards of quality and security. I sincerely hope that the NHFB will facilitate research both in India and abroad, helping clinicians and scientists to work together to understand and find solutions to heart failure-related morbidity and mortality. ” Prof. Ashutosh Sharma, Secretary, Department of Science & Technology (DST) pointed out in his message.
The State Governments/UT Administrations have been requested from time to time to facilitate opening of Janaushadhi Kendras in the premises of Primary Healthcare Centers (PHCs)/Community Health Centers (CHCs)/Hospitals, including super specialty hospitals, by providing rent-free space within their premises. As on 2.8. 2021, about 1,012 Kendras are functioning inside Government’s premises.
Under funding from the Department of Science and Technology, Govt. of India, the Department of Molecular Oncology at the Cancer Institute [WIA] had undertaken research to identify proteins which can be detected in the blood which can help in the diagnosis of epithelial ovarian cancers, which accounts for over 90% of the ovarian cancers.
The measures taken by Department of Commerce to promote exports include various schemes under the Foreign Trade Policy (FTP), assistance under the Market Access Initiative (MAI) scheme, setting up district export hubs, Transport and Market Assistance Scheme etc. Trade delegations/buyer-seller meets with various countries are regularly organized for the benefit of exporters. Airfare support is also provided to the exporters with a turnover of Rs.30 crore and below to encourage participation in business delegations/trade fairs.
According to the health ministry, the Union government is only 2.82 crore doses short of its objective of delivering 51.6 crore doses of COVID-19 vaccinations to states and union territories, as pledged in the Supreme Court of India petition.
Covaxin, India’s first indigenous vaccine to fight Covid-19, is effective against the Delta Plus variant of coronavirus, a study conducted by Indian Council of Medical Research (ICMR) has said, according to news agency ANI. Covaxin has been developed by Bharat Biotech, in collaboration with ICMR.
